28th August 2026 Delegat / WineAuckland-headquartered wine producer and exporter Delegat Group has delivered a strong operating performance for the year ended 30 June 2026, driven by record case sales and higher operating margins.
16th June 2026 Delegat / North AmericaThe reversal of Trump’s trade tariffs has handed global winemaker and exporter Delegat Group a significant financial windfall, prompting a substantial upgrade to its full-year earnings expectations.
20th May 2026 Delegat / WineDelegat Group has concluded its 2026 harvest reporting an excellent quality yield across Marlborough, Hawke’s Bay, and the Barossa Valley.
5th December 2025 Delegat / Wine“Our position is clear: taxes such as these must be passed on to the market” says CEO Murray Annabell with a retail price increase enacted in the US market in Q1.
28th October 2025 Delegat / PeopleDelegat Group has appointed Riki Maden as chief financial officer, effective 1 November 2025.
1st September 2025 Delegat / WineDelegat Group’s revenue, earnings and NPAT are down in a set of annual results it describes as “credible in the context of a challenging global market environment.”
1st July 2025 Delegat / PeopleWine company Delegat Group has promoted from within to fill its vacant chief executive post.
28th April 2025 DelegatThe winemaker is one of the first New Zealand food and beverage exporters to go public with an expected financial hit in the wake of Donald Trump’s new tariff regime.
4th April 2025 Delegat / SanfordNZX-listed exporters have moved to reassure shareholders they are actively working to understand the implications of the new 10% US tariff on their operations.
3rd March 2025 DelegatDelegat faced challenges on many fronts in the first half, from a lower vintage yield to lower sales, pushing its operating net profit after tax down 25% to $28.3m.
9th October 2024 DelegatManaging director of NZX-listed wine company, Steve Carden, has called time at the winemaker and is planning to finish up after three years in the role.
29th August 2024 DelegatBut reported profit falls 52% due to a new requirement to value biological assets at their market value, as opposed to their cost to grow, as well as tax changes.
